0001104659-21-027240.txt : 20210325 0001104659-21-027240.hdr.sgml : 20210325 20210224100955 ACCESSION NUMBER: 0001104659-21-027240 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IBERE PHARMACEUTICALS CENTRAL INDEX KEY: 0001835205 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 981564986 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2005 MARKET STREET, SUITE 2030 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267-765-3222 MAIL ADDRESS: STREET 1: 2005 MARKET STREET, SUITE 2030 CITY: PHILADELPHIA STATE: PA ZIP: 19103 CORRESP 1 filename1.htm

 

IBERE PHARMACEUTICALS

 

2005 Market Street, Suite 2030

Philadelphia, PA 19103

 

February 24, 2021

 

VIA EDGAR  

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attn: Todd K. Schiffman  

 

Re: Ibere Pharmaceuticals

Registration Statement on Form S-1

File No. 333-252863

 

Dear Mr. Schiffman:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned Ibere Pharmaceuticals (the “Company”) respectfully requests that the effective date for the above-referenced Registration Statement be accelerated so that such Registration Statement will be declared effective at 4:00 p.m. Eastern Time on Thursday, February 25, 2021, or as soon thereafter as is practicable, or at such other time as the Company or its outside counsel, Shearman & Sterling LLP, request by telephone that such Registration Statement be declared effective.

 

Please contact our outside counsel, Carmelo M. Gordian of Shearman & Sterling LLP at (512) 647-1902 as soon as the registration statement has been declared effective, or if you have any other questions or concerns regarding this matter. Thank you for your attention to this matter.

 

  Sincerely,
   
  Ibere Pharmaceuticals
   
  /s/ Osagie Imasogie
  Osagie Imasogie
  Chief Executive Officer

 

cc: Carmelo M. Gordian, Shearman & Sterling LLP

 

SHEARMAN.COM
Shearman & Sterling LLP is a limited liability partnership organized in the United States under the laws of the state of Delaware, which laws limit the personal liability of partners.